Diffuse large B cell lymphoma of the spleen is a form of splenic lymphoma, a rare primary neoplasm of the spleen. The clinical presentation is nausea, fatigue, weight loss, and other nonspecific symptoms. The most often seen laboratory finding is anemia. The first sonographic findings are typically splenomegaly and a well-defined hypoechoic mass. Most cases are treated with splenectomies. If the malignancy is confined to the spleen, the prognosis is favorable, but metastasis beyond the spleen is associated with a poor outcome. This case presents a classic case of diffuse large B cell splenic lymphoma with extension into the hilar lymph nodes.
Primary malignancies of the spleen are very rare, with diffuse large B cell lymphoma being an atypical subtype. It is usually found in older men but can occur in any age group or gender. The clinical presentation is nonspecific and can mimic the symptoms of benign abdominal conditions, such as cholelithiasis. For this reason, large B cell lymphoma is often discovered incidentally by sonography.
Case Report
A woman in her late 50s presented with postprandial abdominal pain and bloating. She complained of constant right upper quadrant pain for 1 month and a recent loss of appetite, and she had suffered one recent episode of nausea. Medical history was negative for any malignancy or other disease. No lab results were available at the time of her examination.
A right upper quadrant sonogram was performed using a Toshiba Aplio xV (Tokyo, Japan) with a 6-MHz curved transducer. Borderline hepatomegaly was demonstrated with a measurement of 16.3 cm ( Figure 1 ). Also noted were a 2-cm simple hepatic cyst and a small nonobstructing renal calculus in the upper pole of the right kidney. Because of the suspected hepatic enlargement, the spleen was also imaged. The spleen measured 12.9 × 5.7 × 12.8 cm ( Figure 2 ), which is suggestive of mild splenomegaly. A complex, space-occupying, nonshadowing lesion was seen within the organ measuring 6. 
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A computerized tomography (CT) scan of the abdomen with and without contrast was performed to further evaluate the lesion ( Figure 6 ). The CT revealed a bulky, lowdensity, irregular mass with continuation into the splenic hilum. These bulky hilar soft tissue densities were highly suggestive of lymphadenopathy, which were indicative of a malignant lesion. A total splenectomy was performed. Pathological workup diagnosed primary diffuse large B cell splenic lymphoma, with hilar lymph node involvement.
Discussion
Primary tumors of the spleen, both benign and malignant, are very rare. Primary malignant lymphoma of the spleen (PMLS), also known as splenic lymphoma, is rarer still, making up less than 1% of all non-Hodgkin lymphomas. 1,2 Primary splenic lymphomas have been associated with the hepatitis C virus and HIV. 3 Both viruses are thought to contribute to autoimmune disorders of the bone marrow B cells, which can lead to a malignant transformation. 3 Diffuse large B cell lymphoma (DLBC) is just one form of splenic lymphoma. Other subtypes of splenic lymphomas include splenic villous lymphoma, splenic marginal zone (small B cell) lymphoma, and follicular lymphoma. 4 It affects men more frequently than women and tends to present in late middle age or later, although it can occur at any age. 2, 5 Patients with DLBC typically present with fever, fatigue, weight loss, chills, nausea, palpable splenomegaly, and possibly left upper quadrant pain or other nonspecific systemic symptoms. 6, 7 Cytopenias are the most commonly seen laboratory abnormality, with anemia being the most common. 8 Often, the first sonographic sign of DLBC is a wellcircumscribed, nodular mass within the spleen. 1, 6 The mass is almost always hypoechoic. There may be associated splenomegaly or lymphadenopathy. The mass may contain areas of necrosis. 7 The use of color or power Doppler would demonstrate blood flow within the mass, and spectral analysis would display a low-resistance waveform. Sonographic differentiation between different subtypes of splenic lymphomas is not possible.
DLBC is an aggressive cancer and is quick to spread; therefore, early detection is critical for survival. 5 A splenectomy is the standard treatment for DLBC. 1 Radiation therapy and chemotherapy can be used in conjunction with surgery to eliminate any remaining cancerous cells. They can also be used alone if the patient is not a candidate for surgery, but this is not as effective. In cases of metastasis beyond the spleen, palliative splenectomies can be performed to relieve patient discomfort due to splenomegaly or cytopenia.
The prognosis for the different subtypes of primary malignant splenic lymphoma depends on the stage of the cancer. Stage I is defined as malignancy being limited to the spleen, whereas stages II and III are characterized by hilar node involvement and distant metastasis, respectively. 9 Metastasis outside the spleen and involvement of the hilar nodes are the most important factors in determining a poor outcome. 9 When the cancer is confined to the spleen or its adjacent hilum (stages I and II), the prognosis is quite favorable, with a median survival of 7.48 years. 10
Conclusion
Primary malignant splenic lymphoma is a very rare primary cancer of the spleen that can be curative if detected early. Chemotherapy and radiation therapy are often ineffective, and therefore a total splenectomy is the standard of care. In this case, the patient underwent a splenectomy and removal of the involved hilar nodes. Her status at the time of publication is unknown.
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